WOLFGANG WINKELMAYER to Drug Administration Schedule
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Drug Administration Schedule.
Connection Strength
0.297
-
Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.
Score: 0.105
-
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis. 2012 Sep; 60(3):473-86.
Score: 0.089
-
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007 Aug; 93(8):945-51.
Score: 0.062
-
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006 Mar; 17(3):889-99.
Score: 0.014
-
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Haemophilia. 2005 May; 11(3):261-9.
Score: 0.014
-
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney Int. 2003 Jul; 64(1):295-304.
Score: 0.012